NAYA Biosciences (NAYA) Competitors $0.84 +0.01 (+1.63%) As of 07/18/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock NAYA vs. LGMK, IVF, BBLG, AVGR, DYNT, CUTR, NUWE, SONX, BIOL, and STSSShould you be buying NAYA Biosciences stock or one of its competitors? The main competitors of NAYA Biosciences include LogicMark (LGMK), INVO Fertility (IVF), Bone Biologics (BBLG), Avinger (AVGR), Dynatronics (DYNT), Cutera (CUTR), Nuwellis (NUWE), Sonendo (SONX), BIOLASE (BIOL), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry. NAYA Biosciences vs. Its Competitors LogicMark INVO Fertility Bone Biologics Avinger Dynatronics Cutera Nuwellis Sonendo BIOLASE Sharps Technology LogicMark (NASDAQ:LGMK) and NAYA Biosciences (NASDAQ:NAYA) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk. Do institutionals & insiders have more ownership in LGMK or NAYA? 7.9% of LogicMark shares are held by institutional investors. Comparatively, 12.0% of NAYA Biosciences shares are held by institutional investors. 2.2% of LogicMark shares are held by company insiders. Comparatively, 1.8% of NAYA Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, LGMK or NAYA? LogicMark has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Comparatively, NAYA Biosciences has a beta of 2.03, indicating that its stock price is 103% more volatile than the S&P 500. Does the media prefer LGMK or NAYA? In the previous week, LogicMark's average media sentiment score of 0.00 equaled NAYA Biosciences'average media sentiment score. Company Overall Sentiment LogicMark Neutral NAYA Biosciences Neutral Is LGMK or NAYA more profitable? NAYA Biosciences has a net margin of -119.91% compared to LogicMark's net margin of -141.96%. NAYA Biosciences' return on equity of 0.00% beat LogicMark's return on equity.Company Net Margins Return on Equity Return on Assets LogicMark-141.96% -124.91% -92.05% NAYA Biosciences -119.91%N/A -41.72% Which has preferable valuation and earnings, LGMK or NAYA? NAYA Biosciences has lower revenue, but higher earnings than LogicMark. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLogicMark$9.88M0.18-$14.55M-$223.500.00NAYA Biosciences$6.23M0.09-$8.03MN/AN/A Do analysts rate LGMK or NAYA? NAYA Biosciences has a consensus target price of $24.00, indicating a potential upside of 2,747.65%. Given NAYA Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe NAYA Biosciences is more favorable than LogicMark.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LogicMark 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NAYA Biosciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNAYA Biosciences beats LogicMark on 9 of the 12 factors compared between the two stocks. Get NAYA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for NAYA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NAYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAYA vs. The Competition Export to ExcelMetricNAYA BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.22M$71.11M$5.54B$9.43BDividend YieldN/AN/A4.00%4.03%P/E RatioN/A5.3428.2619.77Price / Sales0.09131.54410.8187.35Price / CashN/A18.4135.8558.18Price / Book-0.417.558.115.65Net Income-$8.03M-$25.04M$3.25B$257.97M7 Day Performance8.64%6.40%1.64%3.75%1 Month Performance-33.11%2.69%7.28%11.53%1 Year PerformanceN/A53.86%33.14%19.22% NAYA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAYANAYA BiosciencesN/A$0.84+1.6%$24.00+2,747.7%N/A$1.22M$6.23M0.0010Gap UpHigh Trading VolumeLGMKLogicMark0.1652 of 5 stars$0.00-3.0%N/A-100.0%$1.90M$9.88M0.0020Gap UpIVFINVO FertilityN/A$0.82-4.5%N/AN/A$1.86M$6.59M-0.0210News CoverageNegative NewsStock SplitGap UpBBLGBone Biologics0.2562 of 5 stars$3.02-3.2%N/A-57.1%$1.70MN/A0.002AVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470DYNTDynatronicsN/A$0.10+22.0%N/A-64.6%$1.01M$33.60M-0.12200Gap UpHigh Trading VolumeCUTRCuteraN/A$0.04-63.9%$3.00+7,592.3%-97.5%$787K$155.21M-0.01460Gap DownHigh Trading VolumeNUWENuwellis3.0633 of 5 stars$7.45+0.9%$714.00+9,483.9%-90.9%$770K$8.74M-0.0170News CoverageAnalyst UpgradeSONXSonendoN/A$1.15flatN/A+1,389.6%$493K$44.40M-0.02250BIOLBIOLASE1.1424 of 5 stars$0.01flat$1.20+12,271.1%-88.2%$324K$48.83M0.00160Gap UpSTSSSharps Technology0.9699 of 5 stars$5.87+0.3%N/AN/A$315KN/A0.003News Coverage Related Companies and Tools Related Companies LGMK Alternatives IVF Alternatives BBLG Alternatives AVGR Alternatives DYNT Alternatives CUTR Alternatives NUWE Alternatives SONX Alternatives BIOL Alternatives STSS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAYA) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTurn $1K into $50K with This DeFi GemI've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NAYA Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NAYA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.